dihexa peptide overview | 1401708-83-5 | BGC70883 Dihexa — Peptide Therapy Online

This stability profile is attributed to the peptide's proline-rich sequence, which confers resistance to cleavage by pepsin and other gastric proteases

Despite the absence of a prolonged anorectic effect, Cagrilintide produced a sustained and significant reduction in body weight in WT mice by 3.4 g after 21 days, while no such effect was observed in KO animals

So far, clinical trials havent resulted in regulatory approval, and pharmaceutical companies havent been motivated to invest in further development

The risk of recurrence will depend on your individual circumstances

To view a copy of this licence, visit About this article Cite this article Jacobsen, J.M., Halling, J.F., Blom, I